 Daniel Vargas
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 5 | 2020 | 325 | 1.220 |
Why?
| | Magnetic Resonance Imaging | 12 | 2024 | 3394 | 0.880 |
Why?
| | Aortic Coarctation | 2 | 2020 | 81 | 0.770 |
Why?
| | Foreign Bodies | 2 | 2024 | 100 | 0.740 |
Why?
| | Computed Tomography Angiography | 4 | 2022 | 115 | 0.680 |
Why?
| | Thoracic Diseases | 2 | 2018 | 14 | 0.680 |
Why?
| | Radiography, Thoracic | 2 | 2018 | 166 | 0.660 |
Why?
| | Tomography, X-Ray Computed | 9 | 2024 | 2512 | 0.610 |
Why?
| | Cardiovascular Diseases | 4 | 2018 | 2006 | 0.610 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 18 | 0.600 |
Why?
| | Thorax | 1 | 2018 | 41 | 0.590 |
Why?
| | Prostheses and Implants | 1 | 2018 | 135 | 0.540 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.510 |
Why?
| | Mediastinal Diseases | 1 | 2015 | 10 | 0.500 |
Why?
| | Coronary Vessel Anomalies | 1 | 2016 | 33 | 0.500 |
Why?
| | Aorta | 4 | 2020 | 408 | 0.500 |
Why?
| | Coronary Angiography | 2 | 2021 | 306 | 0.470 |
Why?
| | Cysts | 1 | 2015 | 109 | 0.470 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 528 | 0.460 |
Why?
| | Coronary Vessels | 1 | 2016 | 239 | 0.440 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1097 | 0.420 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2020 | 185 | 0.400 |
Why?
| | Aneurysm, False | 2 | 2024 | 47 | 0.370 |
Why?
| | Lung | 1 | 2024 | 3938 | 0.370 |
Why?
| | Aortitis | 1 | 2011 | 10 | 0.360 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 792 | 0.360 |
Why?
| | Aortography | 1 | 2011 | 51 | 0.350 |
Why?
| | Vascular Stiffness | 3 | 2023 | 467 | 0.350 |
Why?
| | Angiography | 1 | 2011 | 196 | 0.340 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1501 | 0.330 |
Why?
| | Image Enhancement | 1 | 2011 | 167 | 0.330 |
Why?
| | Cocaine-Related Disorders | 2 | 2008 | 108 | 0.330 |
Why?
| | Postoperative Complications | 2 | 2020 | 2477 | 0.310 |
Why?
| | Echocardiography | 4 | 2024 | 634 | 0.260 |
Why?
| | Quality Improvement | 1 | 2014 | 1101 | 0.250 |
Why?
| | Radiology | 3 | 2015 | 159 | 0.250 |
Why?
| | Respiratory System Abnormalities | 1 | 2024 | 16 | 0.230 |
Why?
| | Contrast Media | 4 | 2020 | 393 | 0.230 |
Why?
| | Humans | 32 | 2024 | 129625 | 0.220 |
Why?
| | Endocarditis, Bacterial | 1 | 2024 | 42 | 0.210 |
Why?
| | Endocarditis | 1 | 2024 | 38 | 0.210 |
Why?
| | Hypertension, Pulmonary | 3 | 2023 | 1894 | 0.190 |
Why?
| | Adipose Tissue | 1 | 2024 | 591 | 0.170 |
Why?
| | Heart Aneurysm | 1 | 2019 | 10 | 0.170 |
Why?
| | Chagas Cardiomyopathy | 1 | 2019 | 22 | 0.160 |
Why?
| | Pericardium | 2 | 2024 | 54 | 0.160 |
Why?
| | Heart | 3 | 2021 | 641 | 0.150 |
Why?
| | Equipment Safety | 1 | 2018 | 37 | 0.150 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 1947 | 0.150 |
Why?
| | Lung Diseases | 1 | 2024 | 741 | 0.140 |
Why?
| | Dyspnea | 1 | 2019 | 239 | 0.140 |
Why?
| | Vasculitis | 1 | 2018 | 65 | 0.140 |
Why?
| | Clinical Competence | 2 | 2015 | 1017 | 0.140 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2020 | 231 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 90 | 0.140 |
Why?
| | Coronary Artery Disease | 2 | 2021 | 679 | 0.140 |
Why?
| | Heart Ventricles | 2 | 2019 | 781 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2016 | 1432 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 506 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 234 | 0.130 |
Why?
| | Equipment Design | 1 | 2018 | 514 | 0.130 |
Why?
| | Cardiomyopathy, Hypertrophic, Familial | 1 | 2016 | 16 | 0.130 |
Why?
| | Arteries | 1 | 2018 | 265 | 0.130 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2016 | 19 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2016 | 33 | 0.120 |
Why?
| | Radiology Department, Hospital | 1 | 2015 | 15 | 0.120 |
Why?
| | Incidental Findings | 1 | 2016 | 80 | 0.120 |
Why?
| | Pulmonary Valve | 1 | 2017 | 93 | 0.120 |
Why?
| | Heart Atria | 1 | 2016 | 129 | 0.120 |
Why?
| | Epinephrine | 1 | 2015 | 141 | 0.120 |
Why?
| | Pneumonia, Bacterial | 1 | 2016 | 115 | 0.110 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 177 | 0.110 |
Why?
| | Tendons | 1 | 2015 | 106 | 0.110 |
Why?
| | Accreditation | 1 | 2014 | 80 | 0.110 |
Why?
| | Anaphylaxis | 1 | 2015 | 98 | 0.110 |
Why?
| | Pneumonectomy | 1 | 2016 | 151 | 0.110 |
Why?
| | Brain Diseases | 2 | 2005 | 136 | 0.110 |
Why?
| | Biological Science Disciplines | 1 | 2013 | 16 | 0.110 |
Why?
| | Prognosis | 2 | 2020 | 3774 | 0.110 |
Why?
| | Education, Graduate | 1 | 2013 | 34 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1021 | 0.100 |
Why?
| | Heart Neoplasms | 1 | 2013 | 50 | 0.100 |
Why?
| | Emergency Medicine | 1 | 2015 | 216 | 0.100 |
Why?
| | Adult | 5 | 2024 | 35599 | 0.100 |
Why?
| | Interprofessional Relations | 1 | 2015 | 277 | 0.100 |
Why?
| | Rhenium | 1 | 2012 | 4 | 0.100 |
Why?
| | Radioisotopes | 1 | 2012 | 31 | 0.100 |
Why?
| | Risk Assessment | 2 | 2018 | 3262 | 0.090 |
Why?
| | Incidence | 1 | 2018 | 2641 | 0.090 |
Why?
| | Decision Support Systems, Clinical | 1 | 2014 | 205 | 0.090 |
Why?
| | Brachytherapy | 1 | 2012 | 104 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4894 | 0.090 |
Why?
| | Internship and Residency | 2 | 2013 | 1050 | 0.090 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 353 | 0.090 |
Why?
| | Cardiomyopathies | 2 | 2016 | 340 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2015 | 730 | 0.080 |
Why?
| | Sternoclavicular Joint | 1 | 2009 | 9 | 0.080 |
Why?
| | Sternum | 1 | 2009 | 25 | 0.080 |
Why?
| | Program Evaluation | 1 | 2013 | 875 | 0.080 |
Why?
| | Female | 9 | 2018 | 68734 | 0.080 |
Why?
| | Glioblastoma | 1 | 2012 | 322 | 0.080 |
Why?
| | Glioma | 1 | 2012 | 348 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2015 | 903 | 0.070 |
Why?
| | Aortic Aneurysm | 1 | 2008 | 65 | 0.070 |
Why?
| | Male | 9 | 2019 | 63670 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 1098 | 0.070 |
Why?
| | Myocarditis | 1 | 2008 | 98 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2018 | 5756 | 0.070 |
Why?
| | Pulse Wave Analysis | 2 | 2018 | 248 | 0.070 |
Why?
| | Child, Preschool | 2 | 2018 | 10490 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 920 | 0.070 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 259 | 0.070 |
Why?
| | Substance-Related Disorders | 2 | 2005 | 1020 | 0.060 |
Why?
| | Radiography | 1 | 2008 | 797 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2020 | 10219 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1705 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1613 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 10 | 0.060 |
Why?
| | Tomography, Emission-Computed | 1 | 2005 | 66 | 0.060 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 77 | 0.060 |
Why?
| | Solvents | 1 | 2005 | 108 | 0.060 |
Why?
| | Central Nervous System Diseases | 1 | 2005 | 69 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2688 | 0.050 |
Why?
| | Middle Aged | 4 | 2018 | 31136 | 0.050 |
Why?
| | Education, Medical, Graduate | 1 | 2007 | 442 | 0.050 |
Why?
| | Hallucinogens | 1 | 2005 | 102 | 0.050 |
Why?
| | Multimodal Imaging | 1 | 2024 | 110 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2012 | 1145 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2342 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 233 | 0.050 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 92 | 0.050 |
Why?
| | Disease Management | 2 | 2016 | 588 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2022 | 14522 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 276 | 0.050 |
Why?
| | Gadolinium | 1 | 2020 | 78 | 0.040 |
Why?
| | Chest Pain | 1 | 2020 | 88 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 520 | 0.040 |
Why?
| | Bolivia | 1 | 2019 | 63 | 0.040 |
Why?
| | Myocardium | 1 | 2024 | 980 | 0.040 |
Why?
| | California | 1 | 2019 | 400 | 0.040 |
Why?
| | Shear Strength | 1 | 2018 | 67 | 0.040 |
Why?
| | Opioid-Related Disorders | 1 | 2005 | 483 | 0.040 |
Why?
| | Stroke Volume | 1 | 2020 | 592 | 0.030 |
Why?
| | Stents | 1 | 2021 | 504 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2018 | 406 | 0.030 |
Why?
| | Aged | 4 | 2019 | 22061 | 0.030 |
Why?
| | Heart Septum | 1 | 2016 | 27 | 0.030 |
Why?
| | Penetrance | 1 | 2016 | 27 | 0.030 |
Why?
| | Mycobacterium chelonae | 1 | 2016 | 8 | 0.030 |
Why?
| | Genes, Dominant | 1 | 2016 | 93 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2018 | 467 | 0.030 |
Why?
| | Sympathomimetics | 1 | 2015 | 23 | 0.030 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2016 | 19 | 0.030 |
Why?
| | Membranes | 1 | 2015 | 20 | 0.030 |
Why?
| | Sarcomeres | 1 | 2016 | 92 | 0.030 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2016 | 40 | 0.030 |
Why?
| | Risk | 1 | 2018 | 855 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2015 | 115 | 0.030 |
Why?
| | Colorado | 2 | 2015 | 4404 | 0.030 |
Why?
| | Mycobacterium avium Complex | 1 | 2016 | 88 | 0.030 |
Why?
| | Radiology Information Systems | 1 | 2015 | 28 | 0.030 |
Why?
| | Calcinosis | 1 | 2017 | 232 | 0.030 |
Why?
| | Atrophy | 2 | 2005 | 169 | 0.030 |
Why?
| | Preoperative Care | 1 | 2017 | 338 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2016 | 220 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 133 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 362 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 581 | 0.030 |
Why?
| | Child | 3 | 2018 | 20884 | 0.030 |
Why?
| | Workload | 1 | 2015 | 153 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 1090 | 0.030 |
Why?
| | Genetic Testing | 1 | 2016 | 430 | 0.030 |
Why?
| | Texas | 1 | 2013 | 237 | 0.030 |
Why?
| | Convection | 1 | 2012 | 6 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2013 | 158 | 0.020 |
Why?
| | Electrocardiography | 1 | 2015 | 611 | 0.020 |
Why?
| | Adolescent | 3 | 2018 | 20412 | 0.020 |
Why?
| | Educational Measurement | 1 | 2013 | 260 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 286 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 171 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3378 | 0.020 |
Why?
| | Funnel Chest | 1 | 2009 | 21 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 808 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2009 | 50 | 0.020 |
Why?
| | Arthritis | 1 | 2009 | 90 | 0.020 |
Why?
| | Disease Progression | 1 | 2016 | 2627 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 375 | 0.020 |
Why?
| | Pregnancy | 2 | 2013 | 6417 | 0.020 |
Why?
| | Osteomyelitis | 1 | 2009 | 121 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 12455 | 0.020 |
Why?
| | Efficiency | 1 | 2007 | 91 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5075 | 0.020 |
Why?
| | Research Support as Topic | 1 | 2007 | 112 | 0.020 |
Why?
| | Personnel Selection | 1 | 2007 | 70 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2009 | 229 | 0.020 |
Why?
| | Toluene | 1 | 2005 | 11 | 0.020 |
Why?
| | Cohort Studies | 1 | 2016 | 5426 | 0.020 |
Why?
| | Infant | 1 | 2018 | 8995 | 0.010 |
Why?
| | Research | 1 | 2007 | 419 | 0.010 |
Why?
| | Prospective Studies | 1 | 2016 | 7135 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2009 | 394 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2005 | 667 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5483 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 2133 | 0.010 |
Why?
| | United States | 1 | 2007 | 13871 | 0.010 |
Why?
| | Animals | 1 | 2012 | 35391 | 0.010 |
Why?
|
|
Vargas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|